325 related articles for article (PubMed ID: 11739622)
1. Cytosolic O-glycosylation is abundant in nerve terminals.
Cole RN; Hart GW
J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
[TBL] [Abstract][Full Text] [Related]
2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
3. A novel post-translational modification in nerve terminals: O-linked N-acetylglucosamine phosphorylation.
Graham ME; Thaysen-Andersen M; Bache N; Craft GE; Larsen MR; Packer NH; Robinson PJ
J Proteome Res; 2011 Jun; 10(6):2725-33. PubMed ID: 21500857
[TBL] [Abstract][Full Text] [Related]
4. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
[TBL] [Abstract][Full Text] [Related]
5. In vivo modulation of O-GlcNAc levels regulates hippocampal synaptic plasticity through interplay with phosphorylation.
Tallent MK; Varghis N; Skorobogatko Y; Hernandez-Cuebas L; Whelan K; Vocadlo DJ; Vosseller K
J Biol Chem; 2009 Jan; 284(1):174-181. PubMed ID: 19004831
[TBL] [Abstract][Full Text] [Related]
6. Does O-GlcNAc play a role in neurodegenerative diseases?
Lefebvre T; Guinez C; Dehennaut V; Beseme-Dekeyser O; Morelle W; Michalski JC
Expert Rev Proteomics; 2005 Apr; 2(2):265-75. PubMed ID: 15892570
[TBL] [Abstract][Full Text] [Related]
7. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.
Khidekel N; Ficarro SB; Peters EC; Hsieh-Wilson LC
Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13132-7. PubMed ID: 15340146
[TBL] [Abstract][Full Text] [Related]
8. Nucleocytoplasmic O-glycosylation: O-GlcNAc and functional proteomics.
Vosseller K; Wells L; Hart GW
Biochimie; 2001 Jul; 83(7):575-81. PubMed ID: 11522385
[TBL] [Abstract][Full Text] [Related]
9. Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex.
Akimoto Y; Comer FI; Cole RN; Kudo A; Kawakami H; Hirano H; Hart GW
Brain Res; 2003 Mar; 966(2):194-205. PubMed ID: 12618343
[TBL] [Abstract][Full Text] [Related]
10. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
[TBL] [Abstract][Full Text] [Related]
11. Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.
Wells L; Vosseller K; Cole RN; Cronshaw JM; Matunis MJ; Hart GW
Mol Cell Proteomics; 2002 Oct; 1(10):791-804. PubMed ID: 12438562
[TBL] [Abstract][Full Text] [Related]
12. Identification of the major site of O-linked beta-N-acetylglucosamine modification in the C terminus of insulin receptor substrate-1.
Ball LE; Berkaw MN; Buse MG
Mol Cell Proteomics; 2006 Feb; 5(2):313-23. PubMed ID: 16244361
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar.
Wells L; Hart GW
FEBS Lett; 2003 Jul; 546(1):154-8. PubMed ID: 12829252
[TBL] [Abstract][Full Text] [Related]
14. Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.
Gao Y; Wells L; Comer FI; Parker GJ; Hart GW
J Biol Chem; 2001 Mar; 276(13):9838-45. PubMed ID: 11148210
[TBL] [Abstract][Full Text] [Related]
15. Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.
Wells L; Gao Y; Mahoney JA; Vosseller K; Chen C; Rosen A; Hart GW
J Biol Chem; 2002 Jan; 277(3):1755-61. PubMed ID: 11788610
[TBL] [Abstract][Full Text] [Related]
16. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.
Akan I; Olivier-Van Stichelen S; Bond MR; Hanover JA
J Neurochem; 2018 Jan; 144(1):7-34. PubMed ID: 29049853
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.
Dong DL; Hart GW
J Biol Chem; 1994 Jul; 269(30):19321-30. PubMed ID: 8034696
[TBL] [Abstract][Full Text] [Related]
18. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
19. Glycosylation of the murine estrogen receptor-alpha.
Cheng X; Hart GW
J Steroid Biochem Mol Biol; 2000 Dec; 75(2-3):147-58. PubMed ID: 11226831
[TBL] [Abstract][Full Text] [Related]
20. O-GLcNAc post-translational modifications regulate the entry of neurons into an axon branching program.
Francisco H; Kollins K; Varghis N; Vocadlo D; Vosseller K; Gallo G
Dev Neurobiol; 2009 Feb 1-15; 69(2-3):162-73. PubMed ID: 19086029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
